Nobuya Kurikawa

An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells

Nobuya Kurikawa, Miwa Suga, Shoko Kuroda et al. · British Journal of Pharmacology · 2003 · 127 citations · Full text

Application of Glutaraldehyde-Crosslinked Chitosan as a Scaffold for Hepatocyte Attachment.

Masaya Kawase, Nobuyasu Michibayashi, Yumiko Nakashima et al. · Biological and Pharmaceutical Bulletin · 1997 · 81 citations · Full text

Tissue Engineering, Engineering, Glycobiology +17

Effectiveness of Fructose-Modified Chitosan as a Scaffold for Hepatocyte Attachment.

Kiyohito Yagi, Nobuyasu Michibayashi, Nobuya Kurikawa et al. · Biological and Pharmaceutical Bulletin · 1997 · 72 citations · Full text

A Novel Inhibitor of Stearoyl-CoA Desaturase-1 Attenuates Hepatic Lipid Accumulation, Liver Injury and Inflammation in Model of Nonalcoholic Steatohepatitis

Nobuya Kurikawa, Toshiyuki Takagi, Satoko Wakimoto et al. · Biological and Pharmaceutical Bulletin · 2013 · 40 citations · Full text

Novel Inhibitor, Immunology, Pathology +23

Novel spiropiperidine-based stearoyl-CoA desaturase-1 inhibitors: Identification of 1′-{6-[5-(pyridin-3-ylmethyl)-1,3,4-oxadiazol-2-yl]pyridazin-3-yl}-5-(trifluoromethyl)-3,4-dihydrospiro[chromene-2,4′-piperidine]

Yoshikazu Uto, Yohei Kiyotsuka, Yuko Ueno et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 31 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +7